Webinar on

Cardiology & Heart Diseases

November 30, 2021

Cardiology 2022

Theme: Building and Beating to the Future of the Heart

It is a privilege to us to be the host of the “2nd Webinar on Cardiology & Heart Diseases” scheduled during November 30, 2021The point of Heart Meeting 2021 is to unite Scientists, Doctors, Researchers, teachers, Business delegates, students and research associates to tell about their experience and knowledge about the research they are working on, the main theme of the Webinar is “Building and Beating to the Future of the Heart”. Heart Webinar incorporates Plenary lectures, keynote lectures by famous personalities from around the world in addition to poster presentation, young researcher sessions, symposiums, workshops, Exhibitions. Skilled understudy groups from colleges and research labs giving an ideal space to share the latest advancements in the Cardiology research. We have dealt with various Cardiac events, Heart Meetings which build great relations, bringing the experts and organizations together.

 

 

Session 1: Juvenile Cardiac Complications

Heart disease is not a major cause of death among children and teenagers, but it is the largest cause of death among adults in the United States. In fact, someone in America dies every 37 seconds from some form of cardiovascular disease. Cardiomyopathy is rare in children but, once diagnosed, carries a considerable risk of morbidity and mortality. Cardiomyopathy is that the primary indication for heart transplantation during childhood, particularly among children >1 year aged .2–5 The causes of paediatric cardiomyopathies are heterogeneous and range from genetic variations that affect basic myocardial processes to systemic diseases that cause diffuse myocardial injury. Risk factors for poor outcomes in paediatric cardiomyopathy include pathogenesis, clinical characteristics, and structural abnormalities affecting geometry and performance, and specific risk factors vary by phenotype.

Session 2: Cardiac Imaging

The use of imaging to review biology and uncover biomarkers of human disease provides a window through which we will phenotype disease in vivo, thereby offering a chance for early diagnosis of disease and assessing the potential value of novel therapies. Because the nuances of disease mechanisms and therefore the subtleties of the responses to therapy are key to understanding and treating disease, imaging has become an important tool for revealing pathogenic mechanisms and for developing therapeutic strategies. The miniaturization of imaging devices with dramatic increases in sensitivity and spatial resolution, including the event of quantitative molecular imaging approaches for evaluating physiology and pathobiology at the cellular and molecular levels provide a singular platform for a replacement era in diagnostic imaging. The crucial role of imaging within the early phenotyping of disease, risk assessment, and management guidance is expanding rapidly in ways previously thought unrealistic.

Session 3: Hypertension and Hypercholesterolemia

The primary way that prime vital sign cause’s harm is by increasing the workload of the guts and blood vessels making them work harder and fewer efficiently. Over time, the force and friction of high vital sign damages the fragile tissues inside the arteries. In turn, LDL (bad) cholesterol forms plaque along tiny tears within the artery walls, signifying the beginning of atherosclerosis. The more the plaque and damage increases, the narrower (smaller) the insides of the arteries become raising vital sign and starting a vicious circle that further harms your arteries, heart and therefore the remainder of your body. This will ultimately cause other conditions starting from arrhythmia to attack and stroke. Researcher’s still work out to know how better these silent killers could be restricted for better heart pumping.

Session 4: Clinical Depression and Anxiety

Symptoms of depression are about 3 times more common in patients after an acute attack than within the general population, which strongly suggests a link between depression and heart condition .While being diagnosed with heart condition or having a attack may increase the danger of depression, depression itself may increase the probabilities of developing heart condition .depression itself is an independent risk factor for adverse cardiac events in patients without known heart condition .Patients with known heart condition , particularly those that develop a attack , are at increased risk of developing new diagnosis of depression. It is somewhat difficult to prove that heart condition directly results in a patient's first-ever episode of depression since many patients may haven't been formally diagnosed with depression before the cardiac event.

Session 5: Interventional Cardiology

Interventional cardiology is a unique medical discipline with a knowledge base of internal medicine and cardiology coupled with physical skill and analytic thinking common to surgical subspecialties. Branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter. More unique to the field of interventional cardiology is the early and proactive management of the occupational hazards of the field, including radiation safety and orthopaedic injuries. Young interventional cardiologists must take these issues seriously and be wary to not hasten their careers. Radiation exposure has serious negative long-term effects, and physicians are wise to educate themselves on the risks of exposure and master radiation safety techniques that can mitigate these risks.

 

  • Juvenile Cardiac Complications
  • Cardiac Imaging
  • Hypertension and Hypercholesterolemia
  • Clinical Depression and Anxiety
  • Interventional Cardiology